Search

everythinglearnresearchcommunity

for

Search:↓

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

Hair loss in three Southeast Asian women with kidney failure may be linked to their anemia treatment with erythropoietin.

Antibiotics often cause skin reactions, making them a major health concern.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

Hair loss from mood stabilizers can grow back, but the reasons why are not fully understood.

The woman's hair loss is likely stress-related and should improve without treatment.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Non-classic congenital adrenal hyperplasia (NCCAH) can mimic PCOS and requires genetic testing for proper diagnosis and treatment.

The document provided instructions for completing a CME exam on diagnosing and managing hair loss.

Higher minoxidil concentration (5%) works better for severe hair loss, with most patients seeing regrowth in 48-60 weeks.

Early diagnosis and treatment of TPP can prevent complications.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

Platelet-Rich Plasma (PRP), a substance from a patient's own blood, can stimulate hair regrowth in people with Androgenetic Alopecia (AGA) who haven't had success with other treatments, but more research is needed to optimize its use.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

The document explains different hair loss types and treatments, emphasizing diagnosis through examination and tests, and specific treatments for each condition.

Androgenic Alopecia, a common hair loss condition, can be effectively treated with finasteride and other treatments.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

The document says that there are treatments for hair and nail diseases.

Upadacitinib may effectively treat alopecia areata without side effects.

Hair loss greatly affects quality of life, and dermatologists are crucial for proper diagnosis and treatment.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Thyroid hormone may be useful for treating various skin conditions and needs more research.

Satoyoshi syndrome is likely an autoimmune disease that mainly affects young women and improves with immune-related treatments.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.